American Century Companies’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,700
Closed -$234K 2905
2025
Q1
$234K Sell
34,700
-38
-0.1% -$269 ﹤0.01% 2725
2024
Q4
$236K Buy
34,738
+2,810
+9% +$18.5K ﹤0.01% 2748
2024
Q3
$265K Buy
31,928
+2,974
+10% +$21.5K ﹤0.01% 2690
2024
Q2
$184K Buy
28,954
+1,272
+5% +$9.78K ﹤0.01% 2739
2024
Q1
$257K Buy
27,682
+4,865
+21% +$57K ﹤0.01% 2698
2023
Q4
$291K Buy
22,817
+386
+2% +$4.02K ﹤0.01% 2581
2023
Q3
$232K Buy
22,431
+6,843
+44% +$79.3K ﹤0.01% 2548
2023
Q2
$204K Buy
+15,588
New +$191K ﹤0.01% 2519

Other funds holding LUNG

American Century Companies's LUNG Position: Q2 2025 in Review

American Century Companies sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 34,700 shares — an estimated $234K sold.

American Century Companies first reported a position in LUNG in Q2 2023 and held it in 8 quarters. The position peaked at $291K in Q4 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

  • American Century Companies reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 34,700 Pulmonx shares in Q2 2025, an estimated $234K.
  • American Century Companies first reported a position in Pulmonx in Q2 2023 and held it in 8 quarters.
  • American Century Companies's Pulmonx position peaked at $291K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.